Louisiana Regulations
Department of Health/Office of Public Health
Vol. 47, No. 1, Louisiana Register 2021-01-20 pp.51-52
PUBLICATION DATE: 01/20/2021
ACTION DATE: 01/20/2021
EFFECTIVE DATE: 01/20/2021
PUBLICATION TYPE: Register
DOCUMENT NUMBER: 2101-039
REGISTER SOURCE: Vol. 46, No. 11, Louisiana Register 2020-11-20 pp.1524-1525
PUBLICATION DATE: 11/20/2020
ACTION DATE: 11/05/2020
EFFECTIVE DATE: 11/03/2020
EXPIRATION DATE: 03/03/2021
PUBLICATION TYPE: Register
DOCUMENT NUMBER: 2010-021
REGISTER SOURCE: Department of Health/Office of Public Health 2020-11-05
PUBLICATION DATE: 11/05/2020
ACTION DATE: 11/05/2020
EFFECTIVE DATE: 11/03/2020
EXPIRATION DATE: 03/03/2021
PUBLICATION TYPE: Agency
DOCUMENT NUMBER: 2010-021
REGISTER SOURCE: Vol. 40, No. 10, Louisiana Register 2020-10-20 pp.1449-1451
PUBLICATION DATE: 10/20/2020
ACTION DATE: 10/20/2020
COMMENT DEADLINE: 11/24/2020
PUBLICATION TYPE: Register
DOCUMENT NUMBER: 2010-009
REGISTER SOURCE: Vol. 46, No. 06, Louisiana Register 2020-06-20 pp.781-782
PUBLICATION DATE: 06/20/2020
ACTION DATE: 06/14/2020
EFFECTIVE DATE: 07/05/2020
EXPIRATION DATE: 11/02/2020
PUBLICATION TYPE: Register
DOCUMENT NUMBER: 2005-026
REGISTER SOURCE: Department of Health/Office of Public Health 2020-06-14
PUBLICATION DATE: 06/14/2020
ACTION DATE: 06/14/2020
EFFECTIVE DATE: 07/05/2020
EXPIRATION DATE: 11/02/2020
PUBLICATION TYPE: Agency
DOCUMENT NUMBER: 2005-026

RULE

Department of Health

Office of Public Health

Public Health—Sanitary Code

Disease Reporting Requirements

(LAC 51:II.105 and 107)

Under the authority of R.S. 40:4 and 40:5, and in accordance with R.S. 49:950 et seq., the Administrative Procedure Act, notice is hereby given that the state health officer, acting through the Louisiana Department of Health, Office of Public Health (LDH-OPH), has amended §105 and 107 of Part II of Title 51 (Public Health-Sanitary Code) of the Louisiana Administrative Code. This Rule is amended to include COVID-19 in the list of diseases and conditions hereby declared reportable as a Class A Disease or Condition.

For the reasons set forth above, the following additions and amendments to Title 51 (Public Health—Sanitary Code) are hereby adopted. This Rule is hereby adopted on the day of promulgation.

Joseph Kanter, MD, MPH

State Health Officer

and

Dr. Courtney N. Phillips

LDH Secretary

2101#039

Title 51

PUBLIC HEALTH—SANITARY CODE

Part II. The Control of Diseases

Chapter 1. Disease Reporting Requirements

§105. Reportable Diseases and Conditions

[formerly paragraph 2:003]

A. - D.1.a.x. ...

xi. Coronavirus Disease 2019 (COVID- 19)/Infections with SARS-CoV-2;

xii. diphtheria;

xiii. Enterobacteriacea, carbenum-resistant;

xiv. fish or shellfish poisoning (domoic acid poisoning, neurotoxic shellfish poisoning, ciguatera, paralytic shellfish poisoning, scombroid);

xv. food-borne illness;

xvi. glanders (Burkholderia mallei);

xvii. Haemophilus influenzae (invasive infection);

xviii. influenza-associated mortality;

xix. measles (rubeola, imported or indigenous);

xx. melioidosis (Burkholderia pseudomallei);

xxi. Neisseria meningitidis (invasive infection);

xxii. outbreaks of any infectious diseases;

xxiii. pertussis;

xxiv. plague (Yersinia pestis);

xxv. poliomyelitis (paralytic and non-paralytic);

xxvi. Pseudomonas aeruginosa, carbapenemresistant;

xxvii. Q fever (Coxiella burnettii);

xxviii. rabies (animal and human);

xxiv. ricin poisoning;

xxx. rubella (congenital syndrome);

xxxi. rubella (German measles);

xxxii. SARS (SARS-CoV-1 infection);

xxxiii. Staphylococcus aureus, vancomycin intermediate or resistant (VISA.VRSA);

xxxiv. staphylococcal enterotoxin B (SEB) pulmonary poisoning;

xxxv. smallpox;

xxxvi. tularemia (Francisella tularensis);

xxxvii. viral hemorrhagic fever (Ebola, Lassa, Marburg, Crimean Congo, etc.); and

xxxviii. yellow fever.

D.2. - E.6. ...

AUTHORITY NOTE: Promulgated in accordance with the provisions of R.S. 40:4(A)(2) and R.S. 40:5(2)(10)(11).

HISTORICAL NOTE: Promulgated by the Department of Health and Hospitals, Office of Public Health, LR 28:1212 (June 2002), amended LR 32:1050 (June 2006), LR 34:2173 (October 2008), repromulgated LR 34:2582 (December 2008), LR 36:1014 (May 2010), repromulgated LR 36:1253 (June 2010), amended LR 39:1053 (April 2013), LR 41:2653 (December 2015), amended by the Department of Health, Office of Public Health, amended LR 45:667 (May 2019), LR 47:51 (January 2021).

§107. Laboratory and Healthcare Facility Reporting

Requirements

[formerly §113]

A. - E. ...

F. Electronic reporting by a laboratory/facility shall include any results, negative or positive, for all components of testing indicative of the following conditions:

1. Coronavirus Disease 2019 (COVID-19)/Infections with SARS-CoV-2;

2. hepatitis C virus;

3. human immunodeficiency virus (HIV), including nucleotide sequences; and

4. syphilis.

G. ...

AUTHORITY NOTE: Promulgated in accordance with the provisions of R.S. 40:4(A)(2) and R.S. 40:5(2)(10)(11).

HISTORICAL NOTE: Promulgated by the Department of Health and Hospitals, Office of Public Health, LR 28:1214 (June 2002), amended LR 32:1052 (June 2006), LR 39:1054 (April 2013), LR 41:2655 (December 2015), amended by Department of Health, Office of Public Health, LR 45:669 (May 2019), LR 47:52 (January 2021).